Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Business Update

We Are Profero


Profero, a healthcare Access Marketing company that partners with biopharmaceutical manufacturers to tackle access and fulfillment challenges, is proud to announce an exciting branding initiative that signals a new era for the firm. The evolved brand will bring a fresh perspective on Proferian values and purpose, clarify its business model and capabilities, and position the company for growth.

Profero is one of the last independently owned Access Marketing companies in the U.S., which allows it to remain nimble and specialized within the industry. Profero is co-owned by Sheila Couch, Chief Executive Officer, and Dominic Lazzaro, Chief Business Officer, who have previously held leadership roles with biopharmaceutical manufacturers. Their experience and knowledge differentiate Profero from competitors, bringing depth and expertise that speak to biopharma marketers' needs and the pressures they face.

While Profero was founded 19 years ago, Couch and Lazzaro purchased the company in 2018 and set a new strategy for growth. Since then, they have defined the Profero Access Marketing business model, value proposition, and a one-of-a-kind culture.

"The Profero team worked diligently to build differentiated Access Marketing capabilities and a resilient team community. We're obsessed with simplifying complex market access challenges, together. Yet the Profero brand image was a dated, inaccurate depiction of who we are today," said Couch. "We're ready for a new era ? where our industry presence is an accurate reflection of the team's talent and the value Profero brings to the clients we serve."

To mark this next chapter, the Profero team created a vibrant new brand identity from the ground up. This includes a formidable personality behind a fresh brand image that reflects the Proferian commitment to one another and to getting medication to patients in need. The creative execution was possible following the addition of David Lubofsky, Executive Creative Director, a published author, and former agency owner with admirable experience in the biopharma industry. With the recent hire of Tony Marchetta as Director of Client Services, Profero is well positioned for increased business growth.

"This isn't just a logo change ? it's a transformation that celebrates our growth and vision for the future. We understand the responsibility that comes with this change and are committed to preserving our values and quality of work. We welcome new team members and clients to our growing community," said Couch.

Profero is dedicated to supporting current Proferians and identifying new Proferians who are eager to bring value and be valued to support growth in this new chapter.

Profero will share news of its rebranding with current and potential clients, and leverage its presence on LinkedIn to reach prospective talent. More details on the company's evolution can be found at WeAreProfero.com.

About Profero

Profero is an Access Marketing company that helps biopharmaceutical clients simplify complex access and fulfillment challenges to benefit their patients and help meet business goals. The company focuses on three distinct areas of access marketing: how and where patients can receive treatment (access), how products and medication get to sites of care (fulfillment), and who pays for products and medication (affordability). Founded in Newtown, Pennsylvania 19 years ago, the company is proud to be a team of vibrant and courageous problem solvers who aim to do good and bring value every day. Visit weareprofero.com to learn more.


These press releases may also interest you

at 00:15
In the news release, AbbVie, Inc.'s Zymaxid tm Implicated in Product Liability Lawsuit Due to Risk of Serious Injury and Death, issued 02-Jul-2024 by Wormington & Bollinger over PRWeb, the source of the release should be "Wormington & Bollinger"...

at 00:00
Author David W. Treaster shares a Christian-based plan that can supplement a cancer patient's medical treatment plan in God Power Cancer Healing Plan: Spiritual Component ($15.99, paperback, 9781662899942; $7.99, e-book, 9781662899959). As long as...

2 jui 2024
In a groundbreaking medical feat, LiverIndia's Dr Karthik Mathivanan, a renowned Liver Transplant surgeon in Chennai with over 15 years of experience in multi-organ transplant surgery, has successfully utilised the emerging field of transplant...

2 jui 2024
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for 225Ac-FL-020, the company's lead radiopharmaceutical,...

2 jui 2024
Vitality Products Inc. (the "Company" or "Vitality"), a manufacturer, marketer and distributor of premium vitamins and supplements, is pleased to report its financial results for the first quarter ended April 30, 2024 and provide a business update....

2 jui 2024
Teva Pharmaceutical Industries Ltd. announced today that it will issue a press release on its second quarter 2024 financial results on Wednesday, July 31, 2024, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live...



News published on and distributed by: